T-group (topology)

3352.1.1 STT3/PglB/AglB transmembrane domain

Ligands and drugs

1,227
Member domains
28
with ligand contacts (≤ 4 Å)
2.3% of members
18
with DrugDomain annotations
1.5% of members
8
with a DrugBank compound
0.7% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

Chemical profiles are computed for X-groups. 3352.1.1 belongs to X-group 3352 STT3/PglB/AglB transmembrane domain, which has 6 proteins with classified ligands. View its chemical profile →

DrugBank compounds

DrugBankPDB ligandNameDomains
DB02306CPLPalmitoyl-Linoleoyl Phosphatidylcholine3
DB03831MPG[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate2
DB00141NAGN-Acetylglucosamine1
DB03945PCN,N,N-Trimethyl-2-(phosphonooxy)ethanaminium1
DB04327PEEPhosphatidylethanolamine1

Most frequently bound compounds

PDB ligandNameDomains in contact
MNmetalMANGANESE (II) ION6
CPL1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE5
MGmetalMAGNESIUM ION5
9UB[(2~{S},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]methyl-[oxidanyl-[(2~{Z},6~{Z},10~{Z})-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]phosphoryl]oxy-phosphinic acid4
EGY(4R,7R)-4-hydroxy-N,N,N-trimethyl-4,9-dioxo-7-[(undecanoyloxy)methyl]-3,5,8-trioxa-4lambda~5~-phosphadocosan-1-aminium4
ELUphosphono [(3~{R},6~{E},10~{E})-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl] hydrogen phosphate4
KZB(2~{S},3~{R},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-[(1~{S},2~{R},3~{R},4~{R},5'~{S},6~{S},7~{R},8~{S},9~{R},12~{R},13~{R},15~{S},16~{S},18~{R})-5',7,9,13-tetramethyl-3,15-bis(oxidanyl)spiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane-6,2'-oxane]-16-yl]oxy-oxane-3,4,5-triol4
PTYPHOSPHATIDYLETHANOLAMINE4
3232-[3,6-bis(dimethylamino)xanthen-9-yl]-5-methanoyl-benzoate2
CLCHLORIDE ION2
MJCdolichyl phosphate mannose2
MPG[(Z)-octadec-9-enyl] (2R)-2,3-bis(oxidanyl)propanoate2
NAmetalSODIUM ION2
ZNmetalZINC ION2
0K3(2Z,6Z,10Z,14Z,18Z,22Z,26Z)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl dihydrogen phosphate1
5TR[(2~{E},6~{E},10~{E},14~{E},18~{Z},22~{E},26~{Z},30~{E},34~{E},38~{E})-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaenyl] dihydrogen phosphate1
7E8(2R)-2,3-DIHYDROXYPROPYL (7Z)-TETRADEC-7-ENOATE1
A1A7X2-deoxy-2-fluoro-1-O-[(S)-hydroxy{[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}phosphoryl]-beta-D-arabinofuranose1
A1I0Mdolichol-phosphate (n=4)1
A1I0Ndolichol-phosphate-mannose (n=2)1